Food and Drug Administration

The FDA’s central role is to protect and promote public health through product oversight, scientific review, inspection, surveillance, and enforcement. Its authority derives from federal statutes, chiefly the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act, which authorize requirements for product safety, manufacturing, labeling, clinical evidence, and postmarket monitoring. The agency does not regulate every health-related product: dietary supplements generally reach the market without premarket approval, while products making disease-treatment claims may fall under drug regulation. FDA decisions are administrative and scientific rather than a substitute for medical advice. The agency also coordinates with state governments, other federal agencies, foreign regulators, and international standard-setting bodies when products or supply chains cross jurisdictions.

FDA oversight differs substantially by product category, and the agency uses risk-based pathways rather than one universal approval process. The Center for Drug Evaluation and Research reviews conventional drugs, while the Center for Biologics Evaluation and Research oversees vaccines, blood products, and many other biologics. Medical devices may require premarket approval, clearance through the 510(k) pathway, or authorization through the De Novo pathway, depending on risk and available predicates. The Center for Food Safety and Applied Nutrition covers foods, food additives, and cosmetics, although cosmetics generally do not receive premarket approval. The agency also regulates tobacco products, animal drugs, veterinary products, and radiation-emitting products such as imaging equipment. Emergency use authorization is a distinct temporary pathway for certain products during declared emergencies.

FDA oversight continues after a product reaches the market, because premarket evidence cannot reveal every rare or long-term risk. Reviewers assess submitted evidence, inspect manufacturing facilities, evaluate labeling, and may require risk-management measures. After marketing, the agency receives adverse-event reports, conducts inspections and laboratory testing, monitors recalls, and can issue warning letters, import alerts, injunction requests, seizures, or criminal referrals. Drug safety monitoring includes the FDA Adverse Event Reporting System and other active surveillance tools; device oversight includes reporting and postmarket studies. FDA inspection authority extends to domestic and foreign facilities that manufacture products entering the United States. Enforcement is shared in practice with customs, state agencies, and regulated firms, which often initiate voluntary recalls.

The FDA’s regulatory reach includes several less visible areas. It oversees color additives, infant formula, medical software, blood establishments, contact lenses, foodborne hazards, and certain products marketed at the boundary between cosmetics, drugs, devices, and supplements. Tobacco regulation was added through the Family Smoking Prevention and Tobacco Control Act of 2009, creating a specialized Center for Tobacco Products and a premarket review system for new tobacco products. The agency also administers the Orphan Drug program, which offers incentives for therapies for rare diseases, and participates in international work addressing counterfeit and substandard medical products. Its historical identity developed from federal food-and-drug enforcement in the early twentieth century, but its present responsibilities are much broader and depend heavily on statutory limits, appropriations, and scientific capacity.

Premarket approval

A regulatory determination made before marketing that a product meets applicable standards of safety, effectiveness, or benefit-risk evidence.

510(k) clearance

A medical-device pathway based on demonstrating substantial equivalence to a legally marketed predicate device.

Biologic

A medical product derived from living systems, including vaccines, blood products, and many cellular or gene-based therapies.

Adverse event

An undesirable medical occurrence associated with use of a product, whether or not the product caused it.

Recall

A firm’s removal or correction of a marketed product because it violates law or may pose a risk.